The medical system is failing GLP-1 patients.
For patients with documented clinical conditions, accessing prescribed GLP-1 medications has become an exhausting battle against insurance denials, high out-of-pocket costs, and endless red tape. We built Cymbl to navigate the barriers you shouldn't have to fight alone.
Why getting treatment today is a frustrating cycle
Default Denials
Insurance companies frequently issue automatic denials for GLP-1 medications, requiring complex appeals and mountains of documentation just to prove clinical necessity.
Unaffordable Cash Prices
When insurance fails, patients are forced to consider cash-pay options that can exceed thousands of dollars a month, making sustainable care impossible for most.
Lack of Clinical Guidance
Many telehealth platforms focus solely on writing a script, leaving patients stranded without support when pharmacies demand prior authorizations or alternatives.
A specialized approach to insurance coverage for clinical conditions
Cymbl is not a cash-pay shortcut. We are a clinical platform dedicated to patients in the US with specific metabolic and weight management needs. We believe if you clinically require a GLP-1, your insurance should cover it. Here is how we build your case.
The Cymbl Protocol
We replace the frustration of navigating the healthcare system with a streamlined, medically rigorous process designed for insurance approval.
Rigorous Clinical Assessment
We start by gathering comprehensive health data to establish clear clinical necessity, ensuring your prescription meets the strict criteria required by major US health plans.
Dedicated Insurance Navigation
Our team handles the prior authorizations, peer-to-peer reviews, and appeals. We speak the language of insurance providers so you don't have to.
Coordinated Care
Once covered, we manage your ongoing prescriptions and adjustments based strictly on clinical outcomes and tolerability, ensuring continuous access to care.